Stock Events

Stock Events

Chengdu Olymvax Biopharmaceuticals (688319.SHG) Q4 2023 Earnings

688319.SHG
Feb 27Confirmed
Q3 2022
Q1 2023
Q2 2023
Q4 2023
-0.03
-0.01
0
0.02

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Chengdu Olymvax Biopharmaceuticals⁩ (⁦688319.SHG⁩) will report earnings of for ⁦Q4 2023⁩ on February 27, 2024.

0 Comments

Share your thoughts